cvt 124 has been researched along with Hypoxia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dalsey, WC; De Garavilla, L; Gao, E; Kaplan, JL; Minczak, B; Victain, M | 1 |
Dalsey, WC; de Garavilla, L; Gao, E; Kaplan, JL; Victain, MS | 1 |
2 other study(ies) available for cvt 124 and Hypoxia
Article | Year |
---|---|
Adenosine A1 antagonism attenuates atropine-resistant hypoxic bradycardia in rats.
Topics: Adenosine A1 Receptor Antagonists; Animals; Atropine; Bradycardia; Disease Models, Animal; Dose-Response Relationship, Drug; Heart Diseases; Hypoxia; Prospective Studies; Rats; Survival Analysis; Vagotomy; Xanthines | 2003 |
Adenosine A1 antagonism attenuates beta-adrenergic-resistant sudden hypoxic cardiac insufficiency.
Topics: Acute Disease; Adenosine A1 Receptor Antagonists; Adrenergic beta-Agonists; Aminophylline; Animals; Cardiotonic Agents; Disease Models, Animal; Dobutamine; Dose-Response Relationship, Drug; Heart Diseases; Hemodynamics; Hypoxia; Male; Pilot Projects; Rats; Rats, Sprague-Dawley; Survival Analysis; Treatment Outcome; Xanthines | 2005 |